5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-5-ethynylpyrimidin-2-yl]-N-methylthiophene-2-sulfonamide
C17H16N6O2S2 — CID 50943531
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-5-ethynylpyrimidin-2-yl]-N-methylthiophene-2-sulfonamide
5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-5-ethynylpyrimidin-2-yl]-N-methylthiophene-2-sulfonamide (PubChem CID 50943531) has the molecular formula C17H16N6O2S2 and a molecular weight of 400.49 g/mol. Its IUPAC name is 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-5-ethynylpyrimidin-2-yl]-N-methylthiophene-2-sulfonamide.
Molecular Properties
| Compound Name | 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-5-ethynylpyrimidin-2-yl]-N-methylthiophene-2-sulfonamide |
|---|---|
| PubChem CID | 50943531 |
| Molecular Formula | C17H16N6O2S2 |
| Molecular Weight | 400.49 g/mol |
| Exact Mass | 400.08 |
| IUPAC Name | 5-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-5-ethynylpyrimidin-2-yl]-N-methylthiophene-2-sulfonamide |
| SMILES | C#Cc1cnc(-c2ccc(S(=O)(=O)NC)s2)nc1Nc1cc(C2CC2)[nH]n1 |
| InChI | InChI=1S/C17H16N6O2S2/c1-3-10-9-19-17(13-6-7-15(26-13)27(24,25)18-2)21-16(10)20-14-8-12(22-23-14)11-4-5-11/h1,6-9,11,18H,4-5H2,2H3,(H2,19,20,21,22,23) |
| InChIKey | OXAPAKHYIZSZGW-UHFFFAOYSA-N |
| XLogP | 2.44 |
| TPSA | 112.66 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 400.49 |
| LogP ≤ 5 | 2.44 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 50943531 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.